Tweet Have a question this is the place for you Source: multiple-sclerosis-research.org
Month: December 2025
NEDA Fudge and Alemtuzumab
Tweet No evidence of disease control is typically no relapse no MRI lesions and no progression. Whilst as mentioned I think progtrssion is a composite surrogate of different biologies the question is how good are drugs at inducing NEDA. Here we hear about alemtuzumab and they tell us that the proportion of patients achieving NEDA-3…
Know One Know them All?
Tweet Are all the anti-CD20 depleting antibodies the same? This study aims to show if rituximab is inferior to ocrelizumab, MSBase said it was. I would ask why? What biology is different?….They are clearly not all the the same in how they do things but they all aim to kill circulating B cells. This study…
Kelly Montelo-Murphy – MSAA’s December 2025 Artist of the Month
MSAA features the work of many talented artists affected by multiple sclerosis as part of our annual MSAA Art Showcase. Each month we share these artists’ inspiring stories and beautiful artwork with you as our Artist of the Month. This month, we celebrate Kelly Montelo-Murphy as December’s … Continue reading → Source: blog.mymsaa.org
Resistance exercise stands out for easing fatigue in multiple sclerosis
Resistance training may be the most effective type of exercise for easing fatigue in people with multiple sclerosis (MS), especially when programs last longer than eight weeks, a meta-analysis found. The study, “Effects of exercise on fatigue and quality of life in multiple sclerosis: a network meta-analysis and systematic review,” was published in the Journal…